CORD-19:ceba28d8304f3df8001164f8edeef545154289f6 / 28716-28972 JSONTXT

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T100","span":{"begin":115,"end":124},"obj":"Disease"},{"id":"T101","span":{"begin":207,"end":216},"obj":"Disease"},{"id":"T37114","span":{"begin":115,"end":124},"obj":"Disease"},{"id":"T30225","span":{"begin":207,"end":216},"obj":"Disease"}],"attributes":[{"id":"A100","pred":"mondo_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A101","pred":"mondo_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A30853","pred":"mondo_id","subj":"T37114","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A47644","pred":"mondo_id","subj":"T30225","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"An ongoing dependence on CD4 T cells for induction and maintenance of virus-specific CD8 bT RM to a persistent CNS infection has clear clinical implications for individuals whose immune status is altered by infection or immunomodulatory therapeutic agents."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T164","span":{"begin":0,"end":256},"obj":"Sentence"},{"id":"TextSentencer_T164","span":{"begin":0,"end":256},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"An ongoing dependence on CD4 T cells for induction and maintenance of virus-specific CD8 bT RM to a persistent CNS infection has clear clinical implications for individuals whose immune status is altered by infection or immunomodulatory therapeutic agents."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T92","span":{"begin":111,"end":114},"obj":"Body_part"}],"attributes":[{"id":"A92","pred":"uberon_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"}],"text":"An ongoing dependence on CD4 T cells for induction and maintenance of virus-specific CD8 bT RM to a persistent CNS infection has clear clinical implications for individuals whose immune status is altered by infection or immunomodulatory therapeutic agents."}